MetaADEDB 2.0 @ LMMD
Linagliptin
(LTXREWYXXSTFRX-QGZVFWFLSA-N)
Structure
SMILES
CC#CCn1c(nc2c1c(=O)n(Cc1nc(C)c3c(n1)cccc3)c(=O)n2C)N1CCC[C@H](C1)N
Type(s)
Approved
ATC code(s)
A10BD11; A10BD19; A10BH05
Molecular Formula:
C25H28N8O2
Molecular Weight:
472.542
Log P:
1.9127
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
1
TPSA:
116.86
CAS Number(s):
668270-12-0
Synonym(s)
1.
Linagliptin
2.
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
3.
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-
4.
BI 1356
5.
BI-1356
6.
BI1356
7.
Tradjenta
8.
Trajenta
9.
1356, BI
External Link(s)
MeSHD000069476
PubChem Compound10096344
BindingDB50228403
ChEBI68610
CHEMBLCHEMBL237500
DrugBankDB08882
DrugCentral4175
IUPHAR/BPS Guide to PHARMACOLOGY6318
KEGGdr:D09566
Therapeutic Target DatabaseD02EYG
ZINC3820029
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PancreatitisFAERS: 196
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
2Blood glucose increasedFAERS: 143
Canada Vigilance: 2
Canada Vigilance
US FAERS
3NauseaFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 93
Canada Vigilance: 7
Canada Vigilance
US FAERS
5DizzinessFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
6Abdominal PainFAERS: 59US FAERS
7PruritusFAERS: 57US FAERS
8UrticariaFAERS: 51SIDER
US FAERS
9HeadacheFAERS: 49
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
10Abdominal discomfortFAERS: 46US FAERS
11Cerebrovascular accidentFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
12VomitingFAERS: 41US FAERS
13MalaiseFAERS: 37US FAERS
14Blood glucose abnormalFAERS: 35US FAERS
15ArthralgiaFAERS: 31SIDER
US FAERS
16AstheniaFAERS: 31US FAERS
17PneumoniaFAERS: 30US FAERS
18Weight decreasedFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Pancreatic carcinomaFAERS: 25US FAERS
20Lip swellingFAERS: 24US FAERS
21Urinary tract infectionFAERS: 24SIDER
US FAERS
22Back PainFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
23HypersensitivityFAERS: 23
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24Myocardial InfarctionFAERS: 21US FAERS
25Unevaluable eventFAERS: 21US FAERS
26Oropharyngeal painFAERS: 20US FAERS
27Chest PainFAERS: 19US FAERS
28ConstipationFAERS: 19SIDER
US FAERS
29FatigueFAERS: 19US FAERS
30Blood glucose decreasedFAERS: 18US FAERS
31Feeling abnormalFAERS: 18US FAERS
32PainFAERS: 18US FAERS
33Lipase increasedFAERS: 17US FAERS
34Peripheral swellingFAERS: 17US FAERS
35PalpitationsFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
36TremorFAERS: 15US FAERS
37SepsisFAERS: 14US FAERS
38SomnolenceFAERS: 14US FAERS
39SwellingFAERS: 14US FAERS
40AngioedemaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41Blood creatinine increasedFAERS: 13US FAERS
42DyspepsiaFAERS: 12US FAERS
43MyalgiaFAERS: 12SIDER
US FAERS
44NasopharyngitisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45Accidental overdoseFAERS: 11US FAERS
46AnxietyFAERS: 11US FAERS
47Pancreatic enzymes increasedFAERS: 11US FAERS
48AlopeciaFAERS: 10US FAERS
49Rash erythematousFAERS: 10US FAERS
50Skin UlcerFAERS: 10US FAERS
51jaundiceFAERS: 10US FAERS
52Amylase increasedFAERS: 9US FAERS
53Diabetes mellitus inadequate controlFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
54FlatulenceFAERS: 9US FAERS
55OverdoseFAERS: 9US FAERS
56Blood glucose fluctuationFAERS: 8US FAERS
57CholelithiasisFAERS: 8US FAERS
58DysphoniaFAERS: 8US FAERS
59ErythemaFAERS: 8US FAERS
60InfluenzaFAERS: 8US FAERS
61Alanine Aminotransferase IncreasedFAERS: 7US FAERS
62DehydrationFAERS: 7US FAERS
63Drug dose omissionFAERS: 7US FAERS
64GoutFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
65LethargyFAERS: 7US FAERS
66Memory impairmentFAERS: 7US FAERS
67Musculoskeletal stiffnessFAERS: 7US FAERS
68SinusitisFAERS: 7US FAERS
69TachycardiaFAERS: 7US FAERS
70AmnesiaFAERS: 6US FAERS
71ArthritisFAERS: 6US FAERS
72Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
73Atrial FibrillationFAERS: 6US FAERS
74CellulitisFAERS: 6US FAERS
75Intestinal ObstructionFAERS: 6US FAERS
76Product quality issueFAERS: 6US FAERS
77Cerebral InfarctionFAERS: 5US FAERS
78Chest discomfortFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
79ChillsFAERS: 5US FAERS
80DementiaFAERS: 5US FAERS
81Diabetes MellitusFAERS: 5SIDER
US FAERS
82Eye painFAERS: 5US FAERS
83NephrolithiasisFAERS: 5US FAERS
84Respiratory FailureFAERS: 5US FAERS
85Retinal migraineFAERS: 5US FAERS
86RhabdomyolysisFAERS: 5US FAERS
87Stevens-Johnson SyndromeFAERS: 5US FAERS
88StomatitisFAERS: 5US FAERS
89ThrombosisFAERS: 5US FAERS
90VertigoFAERS: 5US FAERS
91Blood triglycerides increasedFAERS: 4SIDER
US FAERS
92Blood urea increasedFAERS: 4US FAERS
93BronchitisFAERS: 4US FAERS
94Cardiac ArrestFAERS: 4US FAERS
95CystitisFAERS: 4US FAERS
96DysgeusiaFAERS: 4US FAERS
97EpistaxisFAERS: 4US FAERS
98Feeling jitteryFAERS: 4US FAERS
99FlushingFAERS: 4US FAERS
100FractureFAERS: 4US FAERS
101HydronephrosisFAERS: 4US FAERS
102IleusFAERS: 4US FAERS
103Immune thrombocytopenic purpuraFAERS: 4US FAERS
104Incorrect dose administeredFAERS: 4US FAERS
105InfectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
106Joint swellingFAERS: 4US FAERS
107LymphomaFAERS: 4US FAERS
108Medication residue presentFAERS: 4US FAERS
109StressFAERS: 4US FAERS
110Therapeutic response unexpectedFAERS: 4US FAERS
111WheezingFAERS: 4US FAERS
112AbasiaFAERS: 3US FAERS
113Acute kidney injuryFAERS: 3US FAERS
114Adverse eventFAERS: 3US FAERS
115AgranulocytosisFAERS: 3US FAERS
116Burning sensationFAERS: 3US FAERS
117CataractFAERS: 3US FAERS
118CheilitisFAERS: 3US FAERS
119CholecystitisFAERS: 3US FAERS
120Creatinine renal clearance increasedFAERS: 3US FAERS
121Depressed moodFAERS: 3US FAERS
122DermatitisFAERS: 3SIDER
US FAERS
123DiscomfortFAERS: 3US FAERS
124Drug administration errorFAERS: 3US FAERS
125DysuriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
126EczemaFAERS: 3US FAERS
127EructationFAERS: 3US FAERS
128HepatitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
129HypotensionFAERS: 3US FAERS
130Inappropriate schedule of drug administrationFAERS: 3US FAERS
131Incorrect route of drug administrationFAERS: 3US FAERS
132Limb discomfortFAERS: 3US FAERS
133Limb injuryFAERS: 3US FAERS
134Macular degenerationFAERS: 3US FAERS
135Musculoskeletal PainFAERS: 3US FAERS
136Musculoskeletal discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
137NervousnessFAERS: 3US FAERS
138PolyarthritisFAERS: 3US FAERS
139Renal painFAERS: 3US FAERS
140RetchingFAERS: 3US FAERS
141RhinitisFAERS: 3US FAERS
142SchizophreniaFAERS: 3US FAERS
143SyncopeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Visual ImpairmentFAERS: 3US FAERS
145Wrong technique in drug usage processFAERS: 3US FAERS
146Accidental exposure to product by childFAERS: 2US FAERS
147Acute myocardial infarctionFAERS: 2US FAERS
148AlbuminuriaFAERS: 2US FAERS
149Anaphylactic shockFAERS: 2SIDER
US FAERS
150Angina PectorisFAERS: 2US FAERS
151AscitesFAERS: 2US FAERS
152Atrioventricular BlockFAERS: 2US FAERS
153Biliary sepsisFAERS: 2US FAERS
154BlindnessFAERS: 2US FAERS
155Blood cholesterol increasedFAERS: 2US FAERS
156Blood creatine increasedFAERS: 2US FAERS
157Blood creatinine abnormalFAERS: 2US FAERS
158Blood urine presentFAERS: 2US FAERS
159Bone painFAERS: 2US FAERS
160BronchopneumoniaFAERS: 2US FAERS
161Carotid artery occlusionFAERS: 2US FAERS
162CholangitisFAERS: 2US FAERS
163ChromaturiaFAERS: 2US FAERS
164Device damageFAERS: 2US FAERS
165Diabetic KetoacidosisFAERS: 2US FAERS
166Drug effect incompleteFAERS: 2US FAERS
167Drug prescribing errorFAERS: 2US FAERS
168Dry skinFAERS: 2US FAERS
169Ear discomfortFAERS: 2US FAERS
170Emotional disorderFAERS: 2US FAERS
171Erectile dysfunctionFAERS: 2US FAERS
172Extra dose administeredFAERS: 2US FAERS
173Facial paralysisFAERS: 2US FAERS
174Flank PainFAERS: 2US FAERS
175FormicationFAERS: 2US FAERS
176GastritisFAERS: 2US FAERS
177GastroenteritisFAERS: 2US FAERS
178General physical health deteriorationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
179GlaucomaFAERS: 2US FAERS
180HungerFAERS: 2US FAERS
181HyperchlorhydriaFAERS: 2US FAERS
182InfarctionFAERS: 2US FAERS
183Joint stiffnessFAERS: 2US FAERS
184Malignant neoplasm progressionFAERS: 2US FAERS
185Medication ErrorFAERS: 2US FAERS
186MetastasisFAERS: 2US FAERS
187Mood swingsFAERS: 2US FAERS
188Musculoskeletal chest painFAERS: 2US FAERS
189Neck PainFAERS: 2US FAERS
190NeuralgiaFAERS: 2US FAERS
191NeutropeniaFAERS: 2US FAERS
192No adverse eventFAERS: 2US FAERS
193Pericardial effusionFAERS: 2US FAERS
194Portal Vein ThrombosisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
195Post procedural infectionFAERS: 2US FAERS
196Productive CoughFAERS: 2US FAERS
197Rheumatoid ArthritisFAERS: 2US FAERS
198SciaticaFAERS: 2US FAERS
199Skin lesionFAERS: 2US FAERS
200SneezingFAERS: 2US FAERS
201Throat irritationFAERS: 2US FAERS
202ThrombocytopeniaFAERS: 2US FAERS
203Tinea crurisFAERS: 2US FAERS
204TinnitusFAERS: 2US FAERS
205Transaminases increasedFAERS: 2US FAERS
206Troponin increasedFAERS: 2US FAERS
207Urinary RetentionFAERS: 2US FAERS
208VasculitisFAERS: 2US FAERS
209Vulvovaginal mycotic infectionFAERS: 2US FAERS
210Wrong technique in product usage processFAERS: 2US FAERS
211AbscessFAERS: 1US FAERS
212Accidental exposureFAERS: 1US FAERS
213AcidosisFAERS: 1US FAERS
214Actinic keratosisFAERS: 1US FAERS
215Activities of daily living impairedFAERS: 1US FAERS
216Acute prerenal failureFAERS: 1US FAERS
217Acute respiratory failureFAERS: 1US FAERS
218AgitationFAERS: 1US FAERS
219AgoraphobiaFAERS: 1US FAERS
220Alcohol interactionFAERS: 1US FAERS
221Allergy to chemicalsFAERS: 1US FAERS
222Altered state of consciousnessFAERS: 1US FAERS
223Amylase abnormalFAERS: 1US FAERS
224Anal sphincter atonyFAERS: 1US FAERS
225AngerFAERS: 1US FAERS
226Ankle FractureFAERS: 1US FAERS
227Anorectal discomfortFAERS: 1US FAERS
228AnosmiaFAERS: 1US FAERS
229Aortic AneurysmFAERS: 1US FAERS
230Aortic Valve StenosisFAERS: 1US FAERS
231Aortic occlusionFAERS: 1US FAERS
232AphasiaFAERS: 1US FAERS
233AphoniaFAERS: 1US FAERS
234ArthropathyFAERS: 1US FAERS
235AsthmaFAERS: 1US FAERS
236BedriddenFAERS: 1US FAERS
237Bladder painFAERS: 1US FAERS
238Blood GlucoseFAERS: 1US FAERS
239Blood alkaline phosphatase increasedFAERS: 1US FAERS
240Blood amylase increasedFAERS: 1US FAERS
241Blood blisterFAERS: 1US FAERS
242Blood creatine phosphokinase increasedFAERS: 1US FAERS
243Blood lactate dehydrogenase increasedFAERS: 1US FAERS
244Blood potassium increasedFAERS: 1US FAERS
245Blood sodium decreasedFAERS: 1US FAERS
246Breast cancer recurrentFAERS: 1US FAERS
247BronchospasmFAERS: 1US FAERS
248BursitisFAERS: 1US FAERS
249Cardiac FlutterFAERS: 1US FAERS
250Cardiac enzymes increasedFAERS: 1US FAERS
251Cataract operationFAERS: 1US FAERS
252Cerebral disorderFAERS: 1US FAERS
253ColitisFAERS: 1US FAERS
254ConjunctivitisFAERS: 1US FAERS
255Contraindicated product administeredFAERS: 1US FAERS
256CryingFAERS: 1US FAERS
257DeafnessFAERS: 1US FAERS
258DeliriumFAERS: 1US FAERS
259Depressed Level of ConsciousnessFAERS: 1US FAERS
260Device occlusionFAERS: 1US FAERS
261Device related infectionFAERS: 1US FAERS
262Diabetic NephropathyFAERS: 1US FAERS
263Diabetic RetinopathyFAERS: 1US FAERS
264Diabetic metabolic decompensationFAERS: 1US FAERS
265DisabilityFAERS: 1US FAERS
266DisorientationFAERS: 1US FAERS
267Diverticular perforationFAERS: 1US FAERS
268DroolingFAERS: 1US FAERS
269DrowningFAERS: 1US FAERS
270DysarthriaFAERS: 1US FAERS
271Ear congestionFAERS: 1US FAERS
272Ejection Fraction DecreasedFAERS: 1US FAERS
273Electrocardiogram abnormalFAERS: 1US FAERS
274EmbolismFAERS: 1US FAERS
275Emotional distressFAERS: 1US FAERS
276Enzyme level increasedFAERS: 1US FAERS
277EosinophiliaFAERS: 1US FAERS
278Epidermolysis BullosaFAERS: 1US FAERS
279EpilepsyFAERS: 1US FAERS
280Erythema MultiformeFAERS: 1US FAERS
281Extraocular Muscle ParesisFAERS: 1US FAERS
282Eye irritationFAERS: 1US FAERS
283Failure to ThriveFAERS: 1US FAERS
284Feeling of body temperature changeFAERS: 1US FAERS
285FibromyalgiaFAERS: 1US FAERS
286GastrectomyFAERS: 1US FAERS
287Gastric ulcerFAERS: 1US FAERS
288Gastrointestinal PainFAERS: 1US FAERS
289Gastrointestinal infectionFAERS: 1US FAERS
290Gastrointestinal lymphomaFAERS: 1US FAERS
291Gastrointestinal wall thickeningFAERS: 1US FAERS
292Gingival RecessionFAERS: 1US FAERS
293GingivitisFAERS: 1US FAERS
294Grief reactionFAERS: 1US FAERS
295Head discomfortFAERS: 1US FAERS
296HemiparesisFAERS: 1US FAERS
297HemiplegiaFAERS: 1US FAERS
298Hepatic EncephalopathyFAERS: 1US FAERS
299HepatomegalyFAERS: 1US FAERS
300HepatotoxicityFAERS: 1US FAERS
301HerniaFAERS: 1US FAERS
302HyperphagiaFAERS: 1US FAERS
303HypothyroidismFAERS: 1US FAERS
304Impaired gastric emptyingFAERS: 1US FAERS
305Impaired work abilityFAERS: 1US FAERS
306Incision site painFAERS: 1US FAERS
307Incorrect drug administration durationFAERS: 1US FAERS
308InflammationFAERS: 1US FAERS
309Intentional drug misuseFAERS: 1US FAERS
310Intentional product misuseFAERS: 1US FAERS
311Intercepted medication errorFAERS: 1US FAERS
312Intrusive thoughtsFAERS: 1US FAERS
313Irritable Bowel SyndromeFAERS: 1US FAERS
314Joint injuryFAERS: 1US FAERS
315KetoacidosisFAERS: 1US FAERS
316LacerationFAERS: 1US FAERS
317Laryngeal discomfortFAERS: 1US FAERS
318LeukopeniaFAERS: 1US FAERS
319Limb operationFAERS: 1US FAERS
320Lip and/or oral cavity cancerFAERS: 1US FAERS
321Lipase abnormalFAERS: 1US FAERS
322LipomaFAERS: 1US FAERS
323Loose toothFAERS: 1US FAERS
324Loss of personal independence in daily activitiesFAERS: 1US FAERS
325Lower respiratory tract congestionFAERS: 1US FAERS
326LymphadenopathyFAERS: 1US FAERS
327Macular fibrosisFAERS: 1US FAERS
328Medication residueFAERS: 1US FAERS
329MeningitisFAERS: 1US FAERS
330Meniscus injuryFAERS: 1US FAERS
331Mental impairmentFAERS: 1US FAERS
332Micturition frequency decreasedFAERS: 1US FAERS
333Mitral Valve StenosisFAERS: 1US FAERS
334Mole excisionFAERS: 1US FAERS
335MonoplegiaFAERS: 1US FAERS
336Multiple SclerosisFAERS: 1US FAERS
337MyoclonusFAERS: 1US FAERS
338Nasal discomfortFAERS: 1US FAERS
339Night sweatsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
340NocturiaFAERS: 1US FAERS
341NoduleFAERS: 1US FAERS
342Obesity surgeryFAERS: 1US FAERS
343ObesityFAERS: 1US FAERS
344Ophthalmologic treatmentFAERS: 1US FAERS
345Oral mucosal eruptionFAERS: 1US FAERS
346Oral mucosal erythemaFAERS: 1US FAERS
347Oral painFAERS: 1US FAERS
348OsteoporosisFAERS: 1US FAERS
349Pain of skinFAERS: 1US FAERS
350Palatal swellingFAERS: 1US FAERS
351PallorFAERS: 1US FAERS
352Pancreatic CystFAERS: 1US FAERS
353Pancreatic NeoplasmFAERS: 1US FAERS
354Pancreatic carcinoma recurrentFAERS: 1US FAERS
355Pancreatic enzymes abnormalFAERS: 1US FAERS
356Paranasal sinus discomfortFAERS: 1US FAERS
357ParanoiaFAERS: 1US FAERS
358ParaplegiaFAERS: 1US FAERS
359Percutaneous Coronary InterventionFAERS: 1US FAERS
360Peripheral artery occlusionFAERS: 1US FAERS
361Personality ChangeFAERS: 1US FAERS
362PharyngitisFAERS: 1US FAERS
363PneumonitisFAERS: 1US FAERS
364Polymyalgia RheumaticaFAERS: 1US FAERS
365Portal venous gasFAERS: 1US FAERS
366Post procedural complicationFAERS: 1US FAERS
367PresyncopeFAERS: 1US FAERS
368Product solubility abnormalFAERS: 1US FAERS
369PsoriasisFAERS: 1US FAERS
370Psychiatric symptomFAERS: 1US FAERS
371Pulmonary EmbolismFAERS: 1US FAERS
372Pulmonary thrombosisFAERS: 1US FAERS
373PurpuraFAERS: 1US FAERS
374PurulenceFAERS: 1US FAERS
375PyelonephritisFAERS: 1US FAERS
376Rehabilitation therapyFAERS: 1US FAERS
377Renal artery stent placementFAERS: 1US FAERS
378Respiratory arrestFAERS: 1US FAERS
379Restless Legs SyndromeFAERS: 1US FAERS
380RhinalgiaFAERS: 1US FAERS
381Seronegative arthritisFAERS: 1US FAERS
382Sinus operationFAERS: 1US FAERS
383Skin ErosionFAERS: 1US FAERS
384Skin reactionFAERS: 1US FAERS
385SluggishnessFAERS: 1US FAERS
386Spinal cord infectionFAERS: 1US FAERS
387Subcutaneous AbscessFAERS: 1US FAERS
388Sudden Cardiac DeathFAERS: 1US FAERS
389Sudden deathFAERS: 1US FAERS
390Suicide attemptFAERS: 1US FAERS
391SunburnFAERS: 1US FAERS
392Therapeutic product effect incompleteFAERS: 1US FAERS
393Therapeutic response delayedFAERS: 1US FAERS
394Therapy cessationFAERS: 1US FAERS
395Thermal burnFAERS: 1US FAERS
396ThirstFAERS: 1US FAERS
397Tongue eruptionFAERS: 1US FAERS
398Typhoid FeverFAERS: 1US FAERS
399UlcerFAERS: 1US FAERS
400Upper respiratory tract congestionFAERS: 1US FAERS
401Urinary IncontinenceFAERS: 1US FAERS
402Urine ketone body presentFAERS: 1US FAERS
403Urticarial vasculitisFAERS: 1US FAERS
404Vocal Cord ParalysisFAERS: 1US FAERS
405White blood cell count decreasedFAERS: 1US FAERS
406Wound InfectionFAERS: 1US FAERS
407Wrong drug administeredFAERS: 1US FAERS
408Anovulation28619389CTD
409Bronchial HyperreactivitySIDER
410Demyelinating Diseases29864483CTD
411DiabeticSIDER
412InfestationSIDER
413MalnutritionSIDER
414Motor Disorders29864483CTD
415Neurobehavioral Manifestations29864483CTD
416Ovarian Cysts28619389CTD
417Protein total abnormalCanada Vigilance: 1Canada Vigilance
418Skin irritationCanada Vigilance: 1Canada Vigilance
419Weight Gain28619389CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.